SMIP

Welcome to the Brand page for “SMIP”, which is offered here for Pharmaceuticals, immunotherapeutic compositions for use in the treatment of cancer, autoimmune diseases, vascular diseases, inflammatory conditions and infectious diseases;pharmaceutical drug development services;.

Its status is currently believed to be active. Its class is unavailable. “SMIP” is believed to be currently owned by “Emergent Product Development Seattle, LLC”.


Owner:
EMERGENT PRODUCT DEVELOPMENT SEATTLE, LLC
Owner Details
Description:
Pharmaceuticals, immunotherapeutic compositions for use in the treatment of cancer, autoimmune diseases, vascular diseases, inflammatory conditions and infectious diseases;Pharmaceutical drug development services;
Categories: PHARMACEUTICALS